A Study of the Natural Progression of Interstitial Lung Disease (ILD)

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Interstitial Lung Diseases Connective Tissue Diseases Connective Tissue Disorder Hemic and Lymphatic Diseases Hypersensitivity Hypersensitivity, Delayed Idiopathic Pulmonary Fibrosis Immune System Diseases Lung Diseases Lung Diseases, Interstitial Lymphatic Diseases Lymphoproliferative Disorders Pulmonary Fibrosis Respiratory Tract Diseases Sarcoidosis Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Chicago

Chicago, Illinois, 60637, United States

Location status: Recruiting

Location contact

Mary E Strek, MD

CONTACT

[email protected]

773-702-3609

Mary E Strek, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Interstitial lung disease

Exclusion criteria

Does not have Interstitial lung disease

Treatment and study plan

Primary outcomes

Natural history of course of disease in patients with Interstitial lung disease (ILD)

Time frame: Yearly

We assess mortality roughly yearly but duration is unlimited

Study contacts

Contact information is provided by the study sponsor or research team.

Vanita Patel, MPH

CONTACT

773-702-1012

Sponsors and collaborators

Lead sponsor

University of Chicago

Other

Collaborators

Idiopathic Pulmonary Fibrosis Clinical Research Network
National Institute of Allergy and Infectious Diseases (NIAID)

Registry information

Important dates

Study start: 2005
Primary completion: 2030
Study completion: 2030
First posted: May 7, 2007
Registry last updated: Jun 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed